Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Relationship of late arteriovenous fistula stenosis with soluble E-selectin and soluble EPCR in chronic hemodialysis patients with arteriovenous fistula.

Bilgic MA, Yilmaz H, Bozkurt A, Celik HT, Bilgic IC, Gurel OM, Kirbas I, Bavbek N, Akcay A.

Clin Exp Nephrol. 2015 Feb;19(1):133-9. doi: 10.1007/s10157-014-0955-4. Epub 2014 Mar 14.

PMID:
24627030
2.

Relationship between late arteriovenous fistula (AVF) stenosis and neutrophil-lymphocyte ratio (NLR) in chronic hemodialysis patients.

Yilmaz H, Bozkurt A, Cakmak M, Celik HT, Bilgic MA, Bavbek N, Akcay A.

Ren Fail. 2014 Oct;36(9):1390-4. doi: 10.3109/0886022X.2014.945183.

PMID:
25246339
3.

Soluble endothelial protein C receptor: influence on arteriovenous fistula thrombosis development in hemodialysis patients.

Bilgic A, Ozdemir FN, Bayraktar N, Karakus S, Sasak G, Arat Z, Sezer S, Haberal M.

Am J Nephrol. 2007;27(4):366-72. Epub 2007 Jun 13.

PMID:
17570903
4.

Serum osteoprotegerin level is associated with degree of arteriovenous fistula stenosis in patients with hemodialysis.

Kim HR, Kim HK, Oh DJ.

Clin Nephrol. 2013 Nov;80(5):322-7. doi: 10.5414/CN107979.

PMID:
24091316
5.

Soluble adhesion molecules as markers of native arteriovenous fistula thrombosis in children on uremia.

Fadel FI, Elshamaa MF, Nabhan MM, Essam RG, Kantoush N, El Sonbaty MM, Raafat M, Abd-El Haleem DA.

Blood Coagul Fibrinolysis. 2014 Oct;25(7):675-82. doi: 10.1097/MBC.0000000000000125.

PMID:
24806324
6.

Association between vascular access creation and deceleration of estimated glomerular filtration rate decline in late-stage chronic kidney disease patients transitioning to end-stage renal disease.

Sumida K, Molnar MZ, Potukuchi PK, Thomas F, Lu JL, Ravel VA, Soohoo M, Rhee CM, Streja E, Yamagata K, Kalantar-Zadeh K, Kovesdy CP.

Nephrol Dial Transplant. 2017 Aug 1;32(8):1330-1337. doi: 10.1093/ndt/gfw220.

PMID:
27242372
7.

The relationship between arteriovenous fistula success and inflammation.

Kaygin MA, Halici U, Aydin A, Dag O, Binici DN, Limandal HK, Arslan Ü, Kiymaz A, Kahraman N, Calik ES, Savur AI, Erkut B.

Ren Fail. 2013 Sep;35(8):1085-8. doi: 10.3109/0886022X.2013.815100. Epub 2013 Aug 1.

PMID:
23906289
8.

Evaluation of circulating vascular endothelial growth factor and soluble adhesion molecules as reliable predictors of native arteriovenous fistula thrombosis in chronic hemodialysis patients.

Zohny SF, Abd el-Fattah M.

Clin Biochem. 2008 Oct;41(14-15):1175-80. doi: 10.1016/j.clinbiochem.2008.07.006. Epub 2008 Jul 28.

PMID:
18692491
9.

Prospective validation of an algorithm to maximize native arteriovenous fistulae for chronic hemodialysis access.

Huber TS, Ozaki CK, Flynn TC, Lee WA, Berceli SA, Hirneise CM, Carlton LM, Carter JW, Ross EA, Seeger JM.

J Vasc Surg. 2002 Sep;36(3):452-9.

PMID:
12218966
10.

Does monthly native arteriovenous fistula blood-flow surveillance detect significant stenosis--a randomized controlled trial.

Polkinghorne KR, Lau KK, Saunder A, Atkins RC, Kerr PG.

Nephrol Dial Transplant. 2006 Sep;21(9):2498-506. Epub 2006 Jul 19.

PMID:
16854848
11.

Creation of arteriovenous fistulae for hemodialysis in octogenarians.

Watorek E, Golebiowski T, Kusztal M, Letachowicz K, Letachowicz W, Augustyniak Bartosik H, Garcarek J, Madziarska K, Weyde W, Klinger M.

Hemodial Int. 2014 Jan;18(1):113-7. doi: 10.1111/hdi.12076. Epub 2013 Aug 14.

PMID:
23941579
12.

Association of serum lipid profile and arteriovenous fistula thrombosis in maintenance hemodialysis patients.

Kirkpantur A, Arici M, Altun B, Yilmaz MI, Cil B, Aki T, Bakkaloglu M, Turgan C.

Blood Purif. 2008;26(4):322-32. doi: 10.1159/000132388. Epub 2008 May 19.

PMID:
18487877
13.

Stenosis detection in forearm hemodialysis arteriovenous fistulae by multiphase contrast-enhanced magnetic resonance angiography: preliminary experience.

Planken RN, Tordoir JH, Dammers R, de Haan MW, Oei TK, van der Sande FM, van Engelshoven JM, Leiner T.

J Magn Reson Imaging. 2003 Jan;17(1):54-64.

PMID:
12500274
14.

Administration of a High-Dose Erythropoietin-Stimulating Agent in Hemodialysis Patients is Associated with Late Arteriovenous Fistula Failure.

Jeong HY, Ko EJ, Kim SH, Lee MJ, Cho HJ, Yang DH, Lee SY.

Yonsei Med J. 2017 Jul;58(4):793-799. doi: 10.3349/ymj.2017.58.4.793.

15.

Arteriovenous fistula stenosis in hemodialysis patients is characterized by an increased adventitial fibrosis.

Simone S, Loverre A, Cariello M, Divella C, Castellano G, Gesualdo L, Pertosa G, Grandaliano G.

J Nephrol. 2014 Oct;27(5):555-62. doi: 10.1007/s40620-014-0050-7. Epub 2014 Feb 27.

PMID:
24574138
16.

Vascular access profile in maintenance hemodialysis patients.

Gowda A, Pavan M, Babu K.

Iran J Kidney Dis. 2014 May;8(3):218-24.

17.

[How to predict thrombosis of arteriovenous fistule?].

Kapun S, Zibar L.

Acta Med Croatica. 2008 Feb;62(1):9-13. Croatian.

PMID:
18365494
18.

Association of Genetic Polymorphisms of Renin-Angiotensin-Aldosterone System-Related Genes with Arterio-Venous Fistula Malfunction in Hemodialysis Patients.

Chen YW, Wu YT, Lin JS, Yang WC, Hsu YH, Lee KH, Ou SM, Chen YT, Shih CJ, Lee PC, Chan CH, Chung MY, Lin CC.

Int J Mol Sci. 2016 May 27;17(6). pii: E833. doi: 10.3390/ijms17060833.

19.

Pentraxin 3 and complement cascade activation in the failure of arteriovenous fistula.

Castellano G, Di Vittorio A, Dalfino G, Loverre A, Marrone D, Simone S, Schena FP, Pertosa G, Grandaliano G.

Atherosclerosis. 2010 Mar;209(1):241-7. doi: 10.1016/j.atherosclerosis.2009.08.044. Epub 2009 Aug 31.

PMID:
19772962
20.

Trends in US Vascular Access Use, Patient Preferences, and Related Practices: An Update From the US DOPPS Practice Monitor With International Comparisons.

Pisoni RL, Zepel L, Port FK, Robinson BM.

Am J Kidney Dis. 2015 Jun;65(6):905-15. doi: 10.1053/j.ajkd.2014.12.014. Epub 2015 Feb 7.

PMID:
25662834

Supplemental Content

Support Center